Spermatogenesis inFasciola hepatica:an ultrastructural comparison of the effects of the anthelmintic, thiabendazole (“Fasinex”) and the microtubule inhibitor, tubulozole
- 1 December 1992
- journal article
- research article
- Published by Taylor & Francis in Invertebrate Reproduction & Development
- Vol. 22 (1-3) , 139-150
- https://doi.org/10.1080/07924259.1992.9672266
Abstract
Summary The normal sequence of spermatogenesis in Fasciola hepatica has been established. The single-celled primary spermatogonium—after three mitotic divisons and one meiotic division, accompanied by incomplete cytokinesis—gives rise to a rosette of 32 spermatid cells from which the spermatozoa differentiate. Rosette formation begins to develop at the tertiary spermatogonial stage and leads to individual cells being joined together via a central “cytophore”. As revealed by transmission electron microscopy (TEM), spermatogenesis is readily disrupted by the active sulphoxide metabolite of triclabendazole (TCBZSX), a relatively new benzimidazole anthelmintic. Following short incubation times in this drug (3 h onwards), the spermatogonial stages become mitotically inactive and detached from their normal position close to the wall of the tubule. The rosette stages become increasingly disrupted, with fragmentation of the cytoplasmic cytophore. After longer time periods (12–24 h) the testis tubules were almost completely empty with few spermatogenic stages or mature spermatozoa present. The ultrastructural effects of TCBZ-SX bear some resemblance to those observed after treatment with tubulozole, a potent microtubule inhibitor. The results with the two drugs are discussed in relation to the mode of action of triclabendazole, which at present is unknown.Keywords
This publication has 27 references indexed in Scilit:
- A low-viscosity epoxy resin embedding medium for electron microscopyPublished by Elsevier ,2004
- A possible biochemical mode of action for benzimidazole anthelminticsInternational Journal for Parasitology, 1991
- Influence of the synthetic microtubule inhibitor erbulozole (P.I.N.N.) (R 55 104), a new tubulozole congener, and gamma irradiation on murine tumors in vivoEuropean Journal of Cancer and Clinical Oncology, 1989
- The effect of albendazole and triclabendazole on colchicine binding in the liver fluke Fasciola hepaticaJournal of Veterinary Pharmacology and Therapeutics, 1986
- The effects of tubulazole, a new synthetic microtubule inhibitor on experimental neoplasmsEuropean Journal of Cancer and Clinical Oncology, 1984
- Influence of the antimicrotubule agent, mebendazole, on the secretory activity of intestinal cells ofAscaridia galliProtoplasma, 1980
- Inhibition of tubulin polymerization by MebendazoleBiochemical and Biophysical Research Communications, 1980
- MODIFIED MICROTUBULES IN THE TESTIS OF THE WATER STRIDER, GERRIS REMIGIS (SAY)The Journal of cell biology, 1972
- MICROTUBULES IN THE SPERMATIDS OF THE DOMESTIC FOWLThe Journal of cell biology, 1967
- Substructure of Certain Cytoplasmic Microtubules: An Electron Microscopic StudyScience, 1966